IMMX
Immix Biopharma Inc
NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY
$8.93
+3.48% today
Updated 2026-04-30
Market cap
$505.20M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.89
Dividend yield
—
52W range
$2 – $12
Volume
0.7M
Immix Biopharma Inc (IMMX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |